Fractyl Health, Inc.
GUTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001572616
In the last 90 days, Fractyl Health, Inc. insiders filed 1 open-market purchase and 0 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $56.2M in total; Maverick Capital is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:33 PM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Jan 5, 2026 | Mar 3, 2025 |
| Revenue | $0 | $93.0K |
| Cost of revenue | $0 | $50.0K |
| Gross profit | – | $43.0K |
| Operating expenses | $96.8M | $93.6M |
| Research and development | $74.5M | $70.5M |
| Selling, general and administrative | $22.3M | $23.1M |
| Operating income | -$96.8M | -$93.5M |
| Income tax | $0 | $0 |
| Net income | -$141.0M | -$68.7M |
| EPS, basic | $-1.86 | $-1.62 |
| EPS, diluted | $-1.86 | $-1.62 |
| Weighted shares, basic | 75.8M | 43.5M |
| Weighted shares, diluted | 75.8M | 43.5M |
| Margins and growth | ||
| Gross margin | – | 46.2% |
| Operating margin | – | -100571.0% |
| Net margin | – | -73864.5% |
| Revenue growth, year over year | −100.0% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Jan 5, 2026 | Mar 3, 2025 |
| Cash and equivalents | $81.5M | $67.5M |
| Accounts receivable | – | $0 |
| Inventory | – | $73.0K |
| Total current assets | $87.6M | $71.8M |
| Property, plant and equipment | $2.41M | $2.98M |
| Total assets | $121.4M | $108.1M |
| Accounts payable | $1.57M | $3.24M |
| Total current liabilities | $18.3M | $19.8M |
| Total liabilities | $111.9M | $79.7M |
| Shareholders' equity | $9.46M | $28.4M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Jan 5, 2026 | Mar 3, 2025 |
| Operating cash flow | -$90.3M | -$65.5M |
| Capital expenditures | $557.0K | $1.76M |
| Free cash flow | -$90.9M | -$67.3M |
| Stock-based compensation | $6.68M | $14.4M |
| Investing cash flow | -$557.0K | -$1.76M |
| Financing cash flow | $105.0M | $101.2M |
| Net change in cash | $14.1M | $33.9M |
| Ratio | ||
| Stock-based compensation, % of revenue | – | 15511.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 4, 2026 | 159.2M | +216.5% | SEC |
| May 1, 2026 | 158.6M | +223.9% | SEC |
| Mar 1, 2026 | 158.6M | +224.3% | SEC |
| Oct 31, 2025 | 137.0M | +184.9% | SEC |
| Aug 1, 2025 | 50.3M | +4.9% | SEC |
| May 2, 2025 | 49.0M | +2.3% | SEC |
| Feb 21, 2025 | 48.9M | – | SEC |
| Nov 1, 2024 | 48.1M | – | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.